NeuraMetrix

by NeuraMetrix  · Based in United States → — Measuring Brain Health
Geriatrics Neurology Psychiatry

Regulatory Status Disclosed

Overview

NeuraMetrix is a Software as a Medical Device (SaMD) company that provides a passive digital brain health biomarker called NeuraMetrix Typing Cadence (TC). This technology measures typing inconsistency to detect and monitor neurological diseases and psychiatric disorders. It is intended for use by researchers, physicians, and patients to obtain continuous and precise measurements of brain health.

  • What it does:NeuraMetrix TC continuously measures typing cadence to detect and monitor neurological diseases and psychiatric disorders.
  • Who it is for:The tool is for researchers, physicians, and patients involved in the care of individuals with neurological diseases and psychiatric disorders, including Alzheimer’s, Parkinson’s, Huntington’s, and Depression.
  • How it fits a clinical or practice workflow:It offers a passive and continuous method for monitoring brain health, providing data that can be integrated into ongoing patient assessment and research.
  • Notable capabilities:It can be sold globally for research purposes under Institutional Review Board (IRB) approval.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Passive digital brain health biomarker
  • Measures typing inconsistency
  • Detects neurological diseases
  • Monitors neurological diseases
  • Detects psychiatric disorders
  • Monitors psychiatric disorders
  • Continuous measurement of typing cadence
  • Patented digital biomarker
  • FDA-designated Breakthrough Device for Parkinson's Disease
  • Provides precise and accurate measurements of brain health

Use Cases

  • Detecting neurological diseases
  • Monitoring neurological diseases
  • Detecting psychiatric disorders
  • Monitoring psychiatric disorders
  • Research in neurological and psychiatric disorders
  • Early detection of affective disorders

What Physicians Need to Know

Supported Assay Types
Detects and monitors neurological diseases and psychiatric disorders by continuously measuring typing cadence (Typing Cadence - TC).
Result Interpretation AI
Utilizes a patented digital biomarker (Typing Cadence - TC) that measures typing inconsistency to detect and monitor brain health.
Turnaround Time Impact
Provides passive, continuous, exceptionally precise, and accurate measurements of brain health.
Physician Tip

NeuraMetrix offers a novel digital biomarker for detecting and monitoring neurological and psychiatric disorders through passive typing cadence measurement. This tool can provide continuous and precise data on brain health, potentially aiding in early detection and monitoring of conditions like Alzheimer's, Parkinson's, Huntington's, and depression. While designated a 'Breakthrough Device' by the US FDA for Parkinson's Disease, it is currently available for research under Institutional Review Board (IRB) approval.

The provided text does not specify details about LIS/LIMS integration, QC/QA features, critical value alerts, instrument interfaces, reference range intelligence, or microbiology ID support. The focus is on the proprietary Typing Cadence (TC) digital biomarker and its application in detecting and monitoring brain diseases.

Details

Category Lab & Diagnostics, Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Not applicable AI-estimated
Integrations
EHR Not specified
Specialties Geriatrics, Neurology, Psychiatry

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate NeuraMetrix

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for NeuraMetrix.

Loading videos...

View all on YouTube

Frequently Asked Questions

NeuraMetrix provides physicians with passive, continuous, and precise measurements of brain health to detect and monitor neurological diseases and psychiatric disorders.
NeuraMetrix is for physicians and researchers who care for patients with various neurological diseases and psychiatric disorders.
NeuraMetrix measures typing inconsistency, which is a patented digital biomarker called Typing Cadence (TC).
The website does not provide information on how NeuraMetrix is set up or implemented for use by physicians.
NeuraMetrix is not FDA-cleared or CE-marked, but it can be sold globally under Institutional Review Board (IRB) approval for research.

Related Tools

Vitestro
Vitestro
General Productivity (AI Assistants)
Aletta by Vitestro is the world's first Autonomous Robotic Phlebotomy Device (ARPD) that automates diagnostic blood collection to improve standardization and address staffing shortages.
LabSense AI
LabSense AI
Clinical Decision Support & Reference
LabSense AI is a free, no-signup online tool that explains lab results in plain English, checks against WHO/IFCC reference ranges, and flags critical values.
BloodGPT
BloodGPT
Clinical Decision Support & Reference
3billion
3billion
Clinical Decision Support & Reference
3billion leverages AI to automate variant analysis and enhance accuracy in genetic testing for rare disease diagnosis, making insights more accessible.
Evaxion Biotech
Evaxion Biotech
Drug Discovery & Research
Evaxion Biotech is a pioneering TechBio company that uses its AI-Immunology™ platform to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.
AIRA Matrix AI Solutions
AIRA Matrix
Lab & Diagnostics
AIRA Matrix offers AI solutions to improve efficiency and diagnostic accuracy in pathology lab workflows, primarily for prostate and breast cancer, with services like DPaaS and predictive toxicology.

See all Lab & Diagnostics tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-11-08
AI Tool Finder
AI-powered search. Results may not be comprehensive.